Annual Working Capital
$31.83 M
-$16.62 M-34.30%
01 December 2023
Summary:
COSCIENS Biopharma annual working capital is currently $31.83 million, with the most recent change of -$16.62 million (-34.30%) on 01 December 2023. During the last 3 years, it has risen by +$8.96 million (+39.15%).CSCI Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$20.05 M
-$3.26 M-13.97%
01 September 2024
Summary:
COSCIENS Biopharma quarterly working capital is currently $20.05 million, with the most recent change of -$3.26 million (-13.97%) on 01 September 2024. Over the past year, it has increased by +$8.01 million (+66.54%).CSCI Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSCI Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.3% | +66.5% |
| 3 y3 years | +39.1% | +146.8% |
| 5 y5 years | +198.6% | +539.5% |
CSCI Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -68.0% | -14.0% |
COSCIENS Biopharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $20.05 M(-14.0%) |
| June 2024 | - | $23.31 M(+208.2%) |
| Mar 2024 | - | $7.56 M(-23.5%) |
| Dec 2023 | $31.83 M(-34.3%) | $9.88 M(-17.9%) |
| Sept 2023 | - | $12.04 M(-8.4%) |
| June 2023 | - | $13.15 M(-3.8%) |
| Mar 2023 | - | $13.67 M(+0.4%) |
| Dec 2022 | $48.44 M(-23.2%) | $13.62 M(+5.4%) |
| Sept 2022 | - | $12.92 M(+2.9%) |
| June 2022 | - | $12.56 M(+15.4%) |
| Mar 2022 | - | $10.89 M(+21.4%) |
| Dec 2021 | $63.05 M(+175.7%) | $8.97 M(+10.3%) |
| Sept 2021 | - | $8.13 M(+8.3%) |
| June 2021 | - | $7.50 M(+14.8%) |
| Mar 2021 | - | $6.53 M(+8.8%) |
| Dec 2020 | $22.87 M(+335.6%) | $6.01 M(-1.4%) |
| Sept 2020 | - | $6.09 M(+7.6%) |
| June 2020 | - | $5.66 M(+28.2%) |
| Mar 2020 | - | $4.42 M(+23.5%) |
| Dec 2019 | $5.25 M(-50.7%) | $3.58 M(+14.0%) |
| Sept 2019 | - | $3.14 M(-0.8%) |
| June 2019 | - | $3.16 M(-2.0%) |
| Mar 2019 | - | $3.23 M(-8.0%) |
| Dec 2018 | $10.66 M(+195.1%) | $3.51 M(+13.7%) |
| Sept 2018 | - | $3.08 M(+4.3%) |
| June 2018 | - | $2.96 M(-13.1%) |
| Mar 2018 | - | $3.40 M(-13.2%) |
| Dec 2017 | $3.61 M(-80.5%) | $3.92 M(-46.2%) |
| Sept 2017 | - | $7.29 M(+11.1%) |
| June 2017 | - | $6.56 M(+0.4%) |
| Mar 2017 | - | $6.53 M(-0.9%) |
| Dec 2016 | $18.54 M(-48.5%) | $6.59 M(+9.7%) |
| Sept 2016 | - | $6.01 M(-827.3%) |
| June 2016 | - | -$826.50 K(-29.3%) |
| Mar 2016 | - | -$1.17 M(+19.5%) |
| Dec 2015 | $35.97 M(+25.6%) | -$977.40 K(+173.6%) |
| Sept 2015 | - | -$357.20 K(+83.3%) |
| June 2015 | - | -$194.90 K(-54.1%) |
| Mar 2015 | - | -$424.70 K(-62.6%) |
| Dec 2014 | $28.64 M(-25.4%) | -$1.13 M(+204.4%) |
| Sept 2014 | - | -$372.60 K(+29.3%) |
| June 2014 | - | -$288.20 K(-588.5%) |
| Mar 2014 | - | $59.00 K(-93.3%) |
| Dec 2013 | $38.41 M(+2.2%) | $879.50 K(+4029.1%) |
| Sept 2013 | - | $21.30 K(-71.7%) |
| June 2013 | - | $75.30 K(-70.7%) |
| Mar 2013 | - | $256.90 K(-235.6%) |
| Dec 2012 | $37.60 M(-11.0%) | -$189.50 K(-76.9%) |
| Sept 2012 | - | -$819.90 K(+13.3%) |
| June 2012 | - | -$723.70 K(+25.6%) |
| Mar 2012 | - | -$576.00 K(-265.9%) |
| Dec 2011 | $42.25 M(+37.7%) | $347.10 K(-302.2%) |
| Sept 2011 | - | -$171.70 K(+3.2%) |
| June 2011 | - | -$166.40 K(-46.1%) |
| Mar 2011 | - | -$308.80 K(-62.5%) |
| Dec 2010 | $30.69 M | -$823.20 K(+89.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | -$433.40 K(-51.6%) |
| June 2010 | - | -$895.50 K(-27.2%) |
| Mar 2010 | - | -$1.23 M(+1.2%) |
| Dec 2009 | $29.75 M(-24.8%) | -$1.22 M(+7.0%) |
| Sept 2009 | - | -$1.14 M(+5.6%) |
| June 2009 | - | -$1.08 M(-39.8%) |
| Mar 2009 | - | -$1.79 M(-9.0%) |
| Dec 2008 | $39.55 M(+6.0%) | -$1.96 M(+94.8%) |
| Sept 2008 | - | -$1.01 M(+170.7%) |
| June 2008 | - | -$372.40 K(-154.5%) |
| Mar 2008 | - | $683.90 K(-52.5%) |
| Dec 2007 | $37.33 M(-56.3%) | $1.44 M(-10.9%) |
| Sept 2007 | - | $1.62 M(-36.1%) |
| June 2007 | - | $2.53 M(+416.0%) |
| Mar 2007 | - | $489.90 K(-10.8%) |
| Dec 2006 | $85.41 M(-14.2%) | $549.40 K(-22.8%) |
| Sept 2006 | - | $711.30 K(-20.0%) |
| June 2006 | - | $889.00 K(+5.3%) |
| Mar 2006 | - | $844.10 K(-2.3%) |
| Dec 2005 | $99.50 M(+65.0%) | $863.80 K(+706.5%) |
| Sept 2005 | - | $107.10 K(+29.3%) |
| June 2005 | - | $82.80 K(-352.4%) |
| Mar 2005 | - | -$32.80 K(-70.2%) |
| Dec 2004 | $60.29 M(+6.8%) | -$110.10 K(-32.8%) |
| Sept 2004 | - | -$163.90 K(-171.9%) |
| June 2004 | - | $227.80 K(-25.1%) |
| Mar 2004 | - | $304.30 K(+141.5%) |
| Dec 2003 | $56.45 M(+101.1%) | $126.00 K(-18.4%) |
| Sept 2003 | - | $154.40 K(-282.9%) |
| June 2003 | - | -$84.40 K(-66.0%) |
| Mar 2003 | - | -$248.00 K(+55.9%) |
| Dec 2002 | $28.08 M(-27.3%) | -$159.10 K(-0.1%) |
| Sept 2002 | - | -$159.20 K(-37.5%) |
| June 2002 | - | -$254.90 K(-15.5%) |
| Mar 2002 | - | -$301.80 K(+36.7%) |
| Dec 2001 | $38.61 M(-18.3%) | -$220.70 K(+11.3%) |
| Sept 2001 | - | -$198.30 K(-50.4%) |
| June 2001 | - | -$400.10 K(-58.4%) |
| Mar 2001 | - | -$960.80 K(-29.1%) |
| Dec 2000 | $47.24 M(+63.7%) | -$1.35 M(-12.6%) |
| Sept 2000 | - | -$1.55 M(-0.2%) |
| June 2000 | - | -$1.55 M(+41.0%) |
| Mar 2000 | - | -$1.10 M(-16.0%) |
| Dec 1999 | $28.85 M(+29.8%) | -$1.31 M(+20.4%) |
| Sept 1999 | - | -$1.09 M(+7.1%) |
| June 1999 | - | -$1.02 M(+9.7%) |
| Mar 1999 | - | -$927.80 K(+9.8%) |
| Dec 1998 | $22.23 M(-29.3%) | -$844.90 K(-7.9%) |
| Sept 1998 | - | -$917.10 K(-50.1%) |
| June 1998 | - | -$1.84 M(+4.4%) |
| Mar 1998 | - | -$1.76 M(-18.7%) |
| Dec 1997 | $31.45 M(+21.7%) | -$2.17 M(-23.3%) |
| Sept 1997 | - | -$2.82 M(+129.3%) |
| June 1997 | - | -$1.23 M(-524.7%) |
| Mar 1997 | - | $289.90 K |
| Dec 1996 | $25.83 M | - |
FAQ
- What is COSCIENS Biopharma annual working capital?
- What is the all time high annual working capital for COSCIENS Biopharma?
- What is COSCIENS Biopharma annual working capital year-on-year change?
- What is COSCIENS Biopharma quarterly working capital?
- What is the all time high quarterly working capital for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly working capital year-on-year change?
What is COSCIENS Biopharma annual working capital?
The current annual working capital of CSCI is $31.83 M
What is the all time high annual working capital for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual working capital is $99.50 M
What is COSCIENS Biopharma annual working capital year-on-year change?
Over the past year, CSCI annual working capital has changed by -$16.62 M (-34.30%)
What is COSCIENS Biopharma quarterly working capital?
The current quarterly working capital of CSCI is $20.05 M
What is the all time high quarterly working capital for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly working capital is $23.31 M
What is COSCIENS Biopharma quarterly working capital year-on-year change?
Over the past year, CSCI quarterly working capital has changed by +$8.01 M (+66.54%)